Katie Tifft Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Berwick Rd, Orangeville, PA 17859 Phone: 570-683-5036 |
Mrs. Andrea L Mertz, MS OTR/L Occupational Therapist - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 200 Berwick Rd, Orangeville, Orangeville, PA 17859 Phone: 570-683-8511 |
Kathleen Mangieri Snurkowski, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Berwick Rd, Orangeville, PA 17859 Phone: 570-683-5036 |
Timothy Flynn, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Berwick Rd, Orangeville, PA 17859 Phone: 570-683-5036 |
News Archive
An anti-cancer drug about to be tested in a clinical trial by a biomedical company in Ohio as a possible treatment for Alzheimer's disease has failed to work with the same type of brain plaques that plague Alzheimer's patients, according to results of a study by University of Florida researchers.
In an interview with POLITICO, (Senate Majority Leader Harry) Reid said he was open to a compromise that would salvage about four-fifths of the Bush-era tax cuts. But absent some concession on revenues, the $110 billion in spending cuts ordered by the debt agreement last August would go into effect. "I am not going to back off the sequestration," Reid said. ... the recent House-passed reconciliation bill, which promises to forestall these very same cuts in January, was the last straw for Reid and helped fortify his position.
Lace-up ankle braces can reduce the occurrence of acute ankle injuries in male and female high school basketball players, according to research presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego. The study demonstrated that the braces are effective for athletes both with and without a history of ankle injury.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 2 days ago